CITALOPRAM

Course overview

CITALOPRAM HYDROBROMIDE IS A SELECTIVE SEROTONIN REUPTAKE INHIBITOR. THE PRIMARY FDA-APPROVED CLINICAL USE FOR CITALOPRAM HYDROBROMIDE IS FOR THE TREATMENT OF DEPRESSION IN ADULTS. NON-FDA-APPROVED USES INCLUDE ALCOHOL USE DISORDER, CORONARY ARTERIOSCLEROSIS, OBSESSIVE-COMPULSIVE DISORDER, PANIC DISORDER, POSTMENOPAUSAL FLUSHING, AND PREMENSTRUAL DYSPHORIC DISORDER. THIS ACTIVITY REVIEWS INDICATIONS, MECHANISM OF ACTION, ADMINISTRATION, CONTRAINDICATIONS, MONITORING, AND TOXICITY ASSOCIATED WITH CITALOPRAM AND THE INTERPROFESSIONAL TEAM'S ROLE IN CARING FOR PATIENTS WITH CONDITIONS THAT INDICATE THERAPY WITH CITALOPRAM.